The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009 Jun 20 (6): 1094-9.
Lehnerdt G F, Franz P, Bankfalvi A, Grehl S, Kelava A, Nückel H, Lang S, Schmid K W, Siffert W, Bachmann H
- Page last reviewed:Jul 30, 2019
- Page last updated:Sep 18, 2019
- Content source: